Opportunity ID: 112593

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-11-020
Funding Opportunity Title: Standardization of C-Peptide and HbA1C (UC4)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 09, 2011
Last Updated Date:
Original Closing Date for Applications: Nov 17, 2011
Current Closing Date for Applications: Nov 17, 2011
Archive Date: Dec 18, 2011
Estimated Total Program Funding:
Award Ceiling: $350,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
City or township governments
Special district governments
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
For profit organizations other than small businesses
Small businesses
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA invites applications for a Central Primary Reference Laboratory (CPRL) that will be responsible for improvement and standardization of HbA1c measurements and C-peptide measurements, important for care of diabetes. The significance of HbA1c standardization program has recently been stressed by an international expert committee calling for improved measurement of HbA1c for the diagnosis of diabetes and the importance of C-peptide measurement is heightened based on increasing evidence that preservation of endogenous insulin production in Type 1 diabetes can provide significant long-term clinical benefits in subjects with recent onset Type 1 Diabetes.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-11-020.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.847 ADOBE-FORMS-B2 Adobe-Forms-B2 PKG00070310 Oct 20, 2011 Nov 17, 2011 View

Package 1

Mandatory forms

112593 RR_SF424_1_2-1.2.pdf

112593 PerformanceSite_1_4-1.4.pdf

112593 RR_OtherProjectInfo_1_3-1.3.pdf

112593 RR_KeyPersonExpanded_1_2-1.2.pdf

112593 PHS398_CoverPageSupplement_1_4-1.4.pdf

112593 PHS398_ResearchPlan_1_3-1.3.pdf

112593 PHS398_Checklist_1_3-1.3.pdf

Optional forms

112593 RR_SubawardBudget30-1.2.pdf

112593 PHS398_ModularBudget_1_2-1.2.pdf

112593 RR_Budget-1.1.pdf

112593 PHS_CoverLetter_1_2-1.2.pdf

2025-07-13T13:54:17-05:00

Share This Post, Choose Your Platform!

About the Author: